Company: ADPT
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001193125-25-267061
Chunk: 0

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 1
Chunk 0
---
Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

     September 30, 2025

     December 31, 2024

     (unaudited)

     Assets

     Current assets

     Cash and cash equivalents
      
     $
     55,034

     $
     47,920

     Short-term marketable securities (amortized cost of $157,524 and $174,186, respectively)

     157,735

     174,374

     Accounts receivable, net

     44,821

     41,731

     Inventory, net

     9,933

     8,440

     Prepaid expenses and other current assets

     13,912

     11,287

     Total current assets

     281,435

     283,752

     Long-term assets

     Property and equipment, net

     37,498

     48,616

     Operating lease right-of-use assets

     41,988

     45,767

     Long-term marketable securities (amortized cost of $4,037 and $33,682, respectively)

     4,037

     33,660

     Restricted cash

     2,689

     2,897

     Intangible assets, net

     2,155

     3,425

     Goodwill

     118,972

     118,972

     Other assets

     1,836

     2,287

     Total assets
      
     $
     490,610

     $
     539,376

     Liabilities and shareholders’ equity

     Current liabilities

     Accounts payable
      
     $
     10,267

     $
     7,265

     Accrued liabilities

     7,205

     8,157

     Accrued compensation and benefits

     12,681

     15,838

     Current portion of operating lease liabilities

     9,442

     10,239

     Current portion of deferred revenue

     41,337

     55,689

     Current portion of revenue interest liability, net

     2,429

     865

     Total current liabilities

     83,361

     98,053

     Long-term liabilities

     Operating lease liabilities, less